tetano
Editor, Senior Moderator
J Clin Med
. 2022 Jul 20;11(14):4199.
doi: 10.3390/jcm11144199.
Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients
Mesnad Alyabsi[SUP] 1 2 [/SUP], Omar Aldibasi[SUP] 2 3 [/SUP], Mohammad Bosaeed[SUP] 2 4 5 [/SUP], Maha Alanazi[SUP] 2 4 [/SUP], Anwar Alqarni[SUP] 1 6 [/SUP], Bayan Albdah[SUP] 2 3 [/SUP], Naif Khalaf Alharbi[SUP] 2 4 [/SUP], Suliman Alghnam[SUP] 1 2 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) survivors can have lasting signs and symptoms, including various organ damage, indicating that COVID-19 can be a chronic illness. The current study aims to compare the 30-day hospital readmission and death rate of patients admitted to the hospital with COVID-19 and pneumonia due to other causes. A retrospective cohort study was conducted using data from the Saudi National Guard Health Affairs (NGHA). Records of patients admitted with COVID-19 between 1 March 202 and 31 December 2020 (n = 3597) and pneumonia during 2017 and 2019 (n = 6324) were retrieved and analyzed. We compared the likelihood of 30-day hospital readmission, intensive care unit (ICU) admission, and death between the two groups. Compared with the control group, COVID-19 patients had higher odds of 30-day readmission (odds ratio 1.90, 95% confidence interval 1.61-2.24), higher risk of ICU transfer (hazard ratio 1.85, 95% confidence interval 1.65-2.07), more extended hospital stay (7 vs. 4 days), but less risk of death (hazard ratio 0.18, 95% confidence interval 0.14-0.24). The findings that hospital readmission was higher in COVID-19 recovered patients than in other pneumonia patients inform the current discussion about readmission and death in COVID-19 patients.
Keywords: COVID-19; Saudi Arabia; patient readmission; pneumonia.
. 2022 Jul 20;11(14):4199.
doi: 10.3390/jcm11144199.
Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients
Mesnad Alyabsi[SUP] 1 2 [/SUP], Omar Aldibasi[SUP] 2 3 [/SUP], Mohammad Bosaeed[SUP] 2 4 5 [/SUP], Maha Alanazi[SUP] 2 4 [/SUP], Anwar Alqarni[SUP] 1 6 [/SUP], Bayan Albdah[SUP] 2 3 [/SUP], Naif Khalaf Alharbi[SUP] 2 4 [/SUP], Suliman Alghnam[SUP] 1 2 [/SUP]
Affiliations
- PMID: 35887963
- DOI: 10.3390/jcm11144199
Abstract
Coronavirus disease 2019 (COVID-19) survivors can have lasting signs and symptoms, including various organ damage, indicating that COVID-19 can be a chronic illness. The current study aims to compare the 30-day hospital readmission and death rate of patients admitted to the hospital with COVID-19 and pneumonia due to other causes. A retrospective cohort study was conducted using data from the Saudi National Guard Health Affairs (NGHA). Records of patients admitted with COVID-19 between 1 March 202 and 31 December 2020 (n = 3597) and pneumonia during 2017 and 2019 (n = 6324) were retrieved and analyzed. We compared the likelihood of 30-day hospital readmission, intensive care unit (ICU) admission, and death between the two groups. Compared with the control group, COVID-19 patients had higher odds of 30-day readmission (odds ratio 1.90, 95% confidence interval 1.61-2.24), higher risk of ICU transfer (hazard ratio 1.85, 95% confidence interval 1.65-2.07), more extended hospital stay (7 vs. 4 days), but less risk of death (hazard ratio 0.18, 95% confidence interval 0.14-0.24). The findings that hospital readmission was higher in COVID-19 recovered patients than in other pneumonia patients inform the current discussion about readmission and death in COVID-19 patients.
Keywords: COVID-19; Saudi Arabia; patient readmission; pneumonia.